Evaluation of Novel Obesity and Lipid-Related Indices as Indicators for the Diagnosis of Metabolic Syndrome and Premetabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome

Table 1

Prevalence of MS, pre-MS, and MS components in Chinese women with PCOS based on the uCDS criteria.

	Case (%)
Occurrence of each component of MS, n (%)
Raised BP	176 (16.25%)
Increased TG	253 (23.36%)
Central obesity	248 (22.90%)
Reduced HDL-c	49 (4.52%)
Increased plasma glucose	254 (23.45%)
Number of components
0	550 (50.78%)
1	255 (23.55%)
2	154 (14.22%)
3	82 (7.57%)
4	39 (3.60%)
5	3 (0.28%)
Prevalence of MS	124 (11.45%)
Prevalence of pre-MS	154 (14.22%)

BP, blood pressure; TG, triglycerides; HDL-c, high-density lipoprotein cholesterol.